Kevzara 200 MG/1.14 ML pen INJ 1.14ML
Ended Awarded
- Contract number
- SPE2DB25FVKPJ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $54,203
Award facts
- Contract value 100% obligated
- $54,203.49 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $54,203.49 firm fixed-price delivery order to AmerisourceBergen Drug Corp for KEVZARA 200 mg/1.14 mL pen injections on September 9, 2025, with an ultimate completion date of September 10, 2025. This non-set-aside competitive award represents a direct fulfillment under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime contract vehicle that extends through December 2026 and serves as the primary pharmaceutical supply mechanism for global military healthcare programs. The delivery order will be fulfilled from AmerisourceBergen's Conshohocken, Pennsylvania facility, where the company maintains its corporate headquarters and primary distribution operations.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, leverages its extensive IDC to fulfill episodic medical supply requirements across the federal healthcare system, including the Defense Health Agency, U.S. Coast Guard, and other government medical programs. KEVZARA (sarilumab) is a prescription rheumatoid arthritis biologic medication, representing the specialty pharmaceutical portfolio that AmerisourceBergen routinely supplies through its DLA contracts. The company's demonstrated capability to deliver brand-name specialty medications, generics, vaccines, and medical devices through competitive federal procurement positions it as a critical vendor within the military healthcare supply chain.
Quick answers
Who was awarded contract SPE2DB25FVKPJ?
SPE2DB25FVKPJ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 9, 2025.
How much is contract SPE2DB25FVKPJ worth?
The government has obligated $54,203 on SPE2DB25FVKPJ.
Is contract SPE2DB25FVKPJ an order under another contract?
Yes. SPE2DB25FVKPJ is a delivery order under SPE2DB25D3017, an indefinite delivery contract.
Was contract SPE2DB25FVKPJ competed?
The extent of competition for SPE2DB25FVKPJ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award